Permanent Impairment From Diabetes: The NDIS Pathway

Permanent impairment from diabetes: the NDIS pathway nobody mentions in a diabetes clinic

A man in his late fifties has had type 2 diabetes for twenty years. He lost his left great toe three years ago, then a transmetatarsal amputation last year, and he is now in a removable walker for a chronic ulcer on the other foot. He cannot stand long enough to cook. He has given up driving because he cannot feel the pedals properly. His wife has reduced her hours to help him shower.

Nobody has mentioned the NDIS to him. His endocrinologist manages his glucose. His podiatrist manages his feet. His GP manages his blood pressure and his lipids. Every one of them is doing their job well, and none of their jobs includes asking whether he now has a permanent impairment that the disability system exists to support.

He is 58. He has seven years.

This is the most systematically missed pathway in the relationship between diabetes and disability, and it is missed for a structural reason: diabetes care is organised around glycaemic control and complication prevention, and once a complication becomes permanent, there is no point in the system at which somebody is responsible for asking what happens next.

We are a registered provider operating in New South Wales. No clinical care comes from us and none of this is medical advice. What we can set out is how the access test works and what an application needs, because the reason these applications fail is usually how they were built rather than whether the person qualified.

The rule that makes this possible

The NDIA’s guidance states that access does not depend on how the impairment arose. The scheme has no list of approved causes. It asks whether the impairment is permanent, or likely to be permanent, and whether it substantially reduces functional capacity.

The same guidance makes the specific point that applies here: the NDIS does not fund medication or medical care for treating a chronic condition, but disability supports may still be available where a health condition causes a disability — and the worked example it gives is amputation.

So the position is:

• The diabetes is a chronic health condition. Health system.
• What the diabetes has permanently destroyed is an impairment, assessed on its own terms.

Getting that distinction the wrong way round is the single most common reason these applications are refused. An application that reads as “this person has diabetes and needs help” invites a refusal on the basis that diabetes is a health condition — correctly. An application that reads as “this person has a permanent below-knee amputation with documented loss of mobility, self-care and community access” is an impairment application.

The access test

To meet the disability requirements, a person needs impairment that is permanent or likely to be permanent, substantially reducing functional capacity in at least one of six domains: communication, social interaction, learning, mobility, self-care, self-management.

Permanence means there is no known, available and appropriate treatment that would remedy the impairment. Diabetes complications are generally well suited to this test, because most of them do not reverse — an amputated limb does not grow back, retinopathy-related vision loss does not return, and established neuropathy does not resolve. In that respect these applications are more straightforward than many.

The exception to watch is anything that may still heal or resolve. An active foot ulcer may close. Macular oedema may respond to treatment. Those are properly characterised as ongoing treatment rather than settled impairment, and applications built on them will struggle — which is an argument for building on the permanent component rather than the active one.

The impairments, and what each one engages

Amputation

The clearest pathway, and the one the NDIA’s own guidance names.

The AIHW recorded 6,300 lower limb amputations in people with type 2 diabetes in 2021–22, and Diabetes Feet Australia reports that Australia has the second-highest diabetes-related amputation rate in the OECD.

The List A position matters. Amputation or congenital absence of two limbs is on List A, which means permanence and substantially reduced functional capacity are taken as given. A single amputation is not on List A and is assessed on functional capacity, which it very frequently meets.

Note that amputations in diabetes are often staged — a toe, then a partial foot, then below-knee, sometimes followed by the other side. Somebody who has had bilateral amputations at any level is in different territory from somebody with a single one, and the application should state the full history clearly.

Functional consequences: mobility, standing tolerance, transfers, prosthetic management and the time it takes, falls risk, driving, and the fact that the remaining limb is at high risk and must be protected.

The evidence: the surgical record; a statement from the surgeon or rehabilitation physician confirming the amputation and its permanence; prosthetic assessment; and an occupational therapy functional capacity assessment.

Diabetic retinopathy and vision loss

The strongest List A pathway available in diabetes, and the one least often used.

Diabetic retinopathy damages the small blood vessels of the retina. Advanced disease — proliferative retinopathy, vitreous haemorrhage, tractional retinal detachment, and diabetic macular oedema — can cause permanent and severe vision loss.

The List A position: permanent blindness in both eyes is on List A. That is a specific and powerful entry, and somebody who meets it does not have to argue functional capacity from scratch.

Below that threshold, low vision is assessed on functional capacity, and substantial functional impairment from vision loss is readily evidenced.

Functional consequences: mobility and orientation, reading, driving, managing medication including insulin — which is its own cruel loop, since vision loss from diabetes makes managing the diabetes harder — cooking, employment, and social participation.

The evidence: ophthalmology reports with visual acuity and visual field measurements; a statement on permanence; an orientation and mobility assessment; and an occupational therapy functional capacity assessment. Vision Australia and Guide Dogs services can also assist with assessment and with the application.

A note on the loop: somebody with diabetes-related vision loss who can no longer read an insulin pen dial or a glucose meter display has a safety problem as well as an access question. Talking meters, pens with audible clicks and tactile markers all exist, and there is a separate guide here on self-management adaptations.

Peripheral neuropathy

Common, permanent, progressive, and almost never framed as an impairment.

Diabetic peripheral neuropathy causes loss of sensation to pain, temperature and position, typically in a stocking distribution and sometimes extending to the hands. It also causes painful neuropathy — burning, electric or shooting pain in the same areas.

Functional consequences: loss of balance and proprioception, producing significant falls risk; inability to feel injury, which is the mechanism behind foot disease; loss of fine motor function where hands are affected, which affects buttons, keys, cutlery and insulin devices; inability to drive safely where pedal sensation is lost; and pain affecting sleep and participation.

Domains engaged: mobility and self-care primarily, sometimes self-management.

The evidence: neurologist or endocrinologist assessment, nerve conduction studies where available, a statement on permanence, a falls and balance assessment, and an occupational therapy assessment covering hand function where relevant.

Autonomic neuropathy, which is the under-recognised one

Diabetes damages the autonomic nerves as well as the sensory ones, and the consequences are more disabling than they sound.

Gastroparesis — delayed stomach emptying — is the one worth naming specifically. It causes nausea, vomiting, early satiety, bloating and unpredictable food absorption. In someone on insulin it makes glucose control nearly impossible, because the insulin is timed to a meal that may or may not be absorbed. Severe gastroparesis is genuinely disabling: it affects nutrition, weight, energy, the ability to work, and the ability to leave the house. It is almost never characterised as an impairment, and for some people it should be.

Postural hypotension from autonomic neuropathy causes dizziness and collapse on standing, with substantial falls risk.

Bladder dysfunction, including incomplete emptying and retention.

Loss of hypoglycaemia awareness, which is itself a serious functional impairment — the person no longer gets a warning before a severe low.

Impaired thermoregulation and sweating changes.

Erectile dysfunction, which matters to people and is rarely discussed.

The evidence: gastric emptying studies for gastroparesis, autonomic function testing, specialist statements on permanence, and a functional capacity assessment that captures the practical consequences rather than just the diagnosis.

End-stage kidney disease

The hardest of these to argue, and it deserves an honest account rather than an optimistic one.

Diabetic nephropathy is the leading cause of end-stage kidney disease in Australia. Dialysis is treatment, and treatment is health-funded — the NDIS does not fund dialysis, and will not.

Where the argument sits is in the functional consequences: profound fatigue, the time burden of dialysis three times a week, fluid and dietary restriction, reduced capacity for self-care and daily activity, and the mobility and transport consequences. Those may amount to substantially reduced functional capacity. Whether the NDIA accepts them as a permanent impairment distinct from the treatment of a health condition is genuinely variable, and anybody pursuing this should expect it to be harder than an amputation application and should get advocacy support.

Transplantation also changes the picture, which cuts both ways — a successful transplant may improve function substantially, which is relevant to the permanence assessment.

Stroke, and the cardiovascular complications

Diabetes is a major risk factor for stroke. Where a stroke has caused permanent impairment, that impairment is assessed in its own right — and hemiplegia with severe or total loss of strength and movement in the affected limbs is on List A, as is brain injury causing paraplegia, quadriplegia or tetraplegia.

There is a full stroke library on this site covering the access pathway in detail.

Charcot deformity and chronic foot disease

Permanent foot deformity from Charcot neuroarthropathy, or the consequences of long-term non-weight-bearing and chronic ulceration, can substantially and permanently reduce mobility and self-care capacity. The permanent deformity is the arguable impairment; an active ulcer that may heal is not.

Cognitive change

Diabetes is associated with increased risk of cognitive impairment and vascular dementia, and severe recurrent hypoglycaemia has been associated with cognitive harm. Where permanent cognitive impairment is present, neuropsychological assessment is the document that carries weight.

How to build the application

1. Name the impairment, not the diabetes. The access request is about the amputation, the vision loss, the neuropathy, the gastroparesis. Diabetes appears once, as the cause. This is the most important single thing.

2. Get a specialist statement on permanence, in the scheme’s own language — that the impairment is permanent and that there is no known, available and appropriate treatment that would remedy it. Not a GP letter alone. The surgeon or rehabilitation physician for an amputation. The ophthalmologist for vision loss. The neurologist or endocrinologist for neuropathy. The gastroenterologist for gastroparesis.

3. Get an occupational therapy functional capacity assessment. This is the document that translates impairment into the six domains the scheme assesses, and it most often determines the outcome. It should cover what the person can and cannot do, how long things take, what has been given up, and what happens on a bad day.

4. Add the discipline-specific assessment. Orientation and mobility for vision loss. Falls and balance for neuropathy. Prosthetic assessment for amputation. Neuropsychology for cognitive impairment. Dietetics for gastroparesis.

5. Separate permanent impairment from ongoing treatment. If there is an active ulcer that may heal, build on the amputation and the deformity rather than the ulcer. If macular oedema is being treated, build on the established permanent vision loss rather than the active component.

6. Document the daily reality. A one-page account written by the person or a family member, specific and dated, adds something the clinical reports do not.

7. Address the multiple impairments together. This is a point specific to diabetes. Many people have several at once — reduced vision, neuropathy, an amputation, chronic fatigue. The combined functional effect is greater than any one of them, and an application that presents them separately understates it. Present the cumulative picture.

8. If refused, review. Lodge an internal review inside three months; the agency then has 90 days to decide. Beyond that sits the Administrative Review Tribunal, which took on NDIS matters from the Administrative Appeals Tribunal in October 2024, charging nothing to apply, with free advocacy through the NDIS Appeals programme.

The deadline that matters most

You cannot join the NDIS after turning 65, and the age test applies at the date of application.

In diabetes that bites harder than anywhere else, purely because of when complications arrive. AIHW figures put diabetes at close to one in five Australians aged 80 to 84, against well under one per cent of people in their thirties. Damage accrues across decades, so most people who end up with a permanent diabetes-related impairment reach that point long after the scheme has shut to them.

For those over 65 the pathway is Support at Home through My Aged Care on 1800 200 422, which replaced Home Care Packages on 1 November 2025, capped at roughly $108,000 a year at the highest classification and means tested — against an NDIS plan built on assessed need with no equivalent ceiling.

So the rule is simple and urgent. If somebody is in their late fifties or early sixties with an amputation, significant vision loss, established disabling neuropathy or severe gastroparesis, lodge the application before the 65th birthday, even with incomplete evidence. An application made at 64 remains valid if decided at 65. One made a month later cannot be made at all, whatever the severity of the impairment.

Nobody in the diabetes system will say this. If you are reading this and it describes somebody you know, you may be the only person who is going to.

Why this group is invisible

Self-identification. A person with diabetes thinks of themselves as somebody with diabetes, not as a person with a disability. Both can be true and only one of them opens a funding pathway.

Clinical framing. Diabetes care is oriented to glycaemic control and complication prevention. An HbA1c gets taken and the feet get looked at. Whether the person can actually manage at home is not usually on the agenda, and the NDIS is seldom raised at all.

No handover point. There is no moment in the diabetes pathway at which somebody is responsible for asking whether a complication has become a permanent impairment and what should happen about it.

The complication is treated as a diabetes problem. An amputation in a diabetes clinic is a diabetes outcome. In the disability system it is an amputation. The same event, two completely different framings, and only one of them leads anywhere useful.